Ben Atkins | Vice President, Communications and Investor Relations |
Dr. Roger Crystal | Chief Executive Officer |
Dr. Phil Skolnick | Chief Scientific Officer |
David O'Toole | Chief Financial Officer |
Matt Ruth | Chief Commercial Officer |
Brandon Folkes | Cantor Fitzgerald |
Leland LelGershell | Oppenheimer |
David Bautz | Zacks |
Greetings, and welcome to Opiant Pharmaceuticals First Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Ben Atkins, Vice President of Communications and Investor Relations.